Johns Hopkins Health Alert
Electroconvulsive Therapy Update
Some 100,000 Americans undergo electroconvulsive therapy (ECT) treatments for depression each year. Deciding whether ECT is a good treatment option for you or a loved one can be a difficult decision. But it is an option worth exploring when depression is severe. In this Health Alert, Johns Hopkins provides a primer on ECT.
Modern-day ECT is a far cry from the decades-old methods that earned ECT its sinister reputation. The treatment has evolved into a relatively painless procedure with proven effectiveness in the fight against depression. It has survived its critics because it is safe when administered by experienced doctors and nurses and because it works.
ECT involves passing a carefully controlled electrical current through a person's brain to trigger a seizure -- a rapid discharge of nerve impulses throughout the brain. The electricity is passed between two electrodes that are placed on the patient's scalp. When the current is passed between the electrodes, a generalized seizure that typically lasts for 30–60 seconds is produced in the brain.
Exactly how the seizure alleviates depression remains a mystery to neuroscientists and psychiatrists. Depression is believed to be caused, at least in part, by an imbalance in the brain's chemical messenger system. ECT somehow works to rebalance that system. Many rodent studies have been conducted in hopes of better understanding ECT's mechanism of action, but they have not been informative in any definitive way.
What scientists do know is that, despite the increase in brain activity caused by the induced seizure, there is a net decrease in activity in certain areas of the brain following ECT. One hypothesis is that, by inducing a seizure -- the absolute strongest stimulus the brain can take -- there is a consequent dampening down of brain circuits afterward. This quieting of the brain, it is thought, may help alleviate symptoms of depression.
Doctors who perform ECT essentially treat people with depression who are medication resistant or who have suboptimal responses to the medicines, and about 85% of these difficult-to-treat patients improve with ECT. This is a remarkably high response rate in a severely depressed group of people.
Posted in Depression and Anxiety on November 23, 2009
Reviewed January 2011
Medical Disclaimer: This information is not intended to substitute for the advice of a physician. Click here for additional information: Johns Hopkins Health Alerts Disclaimer
Notify Me
Would you like us to inform you when we post new Depression and Anxiety Health Alerts?
Comments
Health Alerts registered users may post comments and share experiences here at their own discretion. We regret that questions on individual health concerns to the Johns Hopkins editors cannot be answered in this space.
The views expressed here do not constitute medical advice, and do not represent the position of Johns Hopkins Medicine or Remedy Health Media, LLC, which has no responsibility for any comments posted on this site.
Post a Comment
Already a subscriber?
Login
New to Johns Hopkins Health Alerts?
